meta|COVID-19
  • Dynamic meta-analysis of evidences about drug efficacy and safety

    518

  • adjuvant therapies
  • anticoagulant
  • anticoagulant, curative dose
  • anticoagulant, prophylactic dose
  • Bivalirudin
  • heparin at therapeutic dose
  • sulodexide
  • colchicine
  • face mask
  • febuxostat
  • hydrogen-oxygen nebulizer
  • hyperbaric oxygen
  • nintedanib
  • pulmonary rehabilitation
  • thalidomide
  • vitamin C
  • anti-inflammatoty and immuno-therapy
  • A EFFACER anticorps
  • acalabrutinib
  • anti-inflammatory therapies
  • IFX-1
  • mepolizumab
  • naproxen, ibuprofen
  • non-steroidal anti-inflammatory drugs
  • Celecoxib
  • Ibuprofen
  • Indomethacin
  • sodium aescinate
  • Apilimod
  • corticosteroids
  • ciclesonide
  • dexamethasone
  • Hydrocortisone
  • inhaled steroids
  • low-dose corticosteroids
  • methylprednisolone
  • imatinib
  • Immunostimulants drugs
  • anti-PD-1 antibody
  • CD24Fc
  • convalescent plasma treatment
  • immunoglobulin therapy
  • emapalumab
  • inactivated mycobacterium vaccine
  • interferon
  • interferon / TFF2
  • SNG001 inhaled interferon beta
  • Interleukin-2
  • neutralizing antibody
  • bamlanivimab (LY-CoV555)
  • casirivimab and imdevimab
  • rhG-CSF
  • Vitamin D
  • Immunosuppressants drugs
  • adalimumab
  • anakinra
  • anti-interleukin-6
  • clazakizumab
  • sarilumab
  • sarilumab azithromycin hydroxychloroquine
  • sarilumab high dose (400mg)
  • sarilumab low dose (200mg)
  • siltuximab
  • tocilizumab
  • baricitinib
  • baricitinib plus remdesivir
  • eculizumab
  • jakotinib
  • lenzilumab
  • ruxolitinib
  • tacrolimus
  • tetrandrine
  • leflunomide
  • pirfenidone
  • Polyinosinic-Polycytidylic Acid
  • sargramostim
  • thymosin
  • antiandrogenic
  • 5-alpha-reductase inhibitors
  • antiviral and associated therapy
  • ASC09/ritonavir
  • azithromycin
  • azvudine
  • baloxavir marboxil
  • carrimycin
  • chloroquine and derivatives
  • chloroquine
  • hydroxychloroquine
  • danoprevir / ritonavir
  • darunavir cobicistat
  • darunavir/cobicistat plus chloroquine
  • doxycycline
  • favipiravir
  • fluvoxamine
  • hydroxychloroquine plus macrolides
  • ivermectin
  • leronlimab
  • lopinavir / ritonavir plus ribavirin
  • lopinavir/ritonavir
  • lopinavir/ritonavir plus chloroquine
  • lopinavir/ritonavir plus interferon ß-1a
  • lopinavir/ritonavir, ribavirin and interferon beta-1b
  • meplazumab
  • nitazoxanide
  • oseltamivir
  • oseltamivir plus chloroquin
  • remdesivir
  • Renin-angiotensin-system-acting agents
  • angiotensin converting enzyme inhibitors (ACEIs)
  • angiotensin receptor blockers (ARBs)
  • angiotensin-(1-7)
  • discontinuation of ACEI/ARB
  • RAS blocker withdrawal
  • rhACE2
  • ribavirin
  • ritonavir
  • sofosbuvir and daclatasvir
  • tenofovir/emtricitabine
  • tenofovir/emtricitabine plus hydroxychloroquine
  • tranexamic acid
  • triazavirin
  • umifenovir (arbidol)
  • control
  • placebo
  • prone positioning
  • standard of care
  • honey
  • miscellaneous
  • acetylcysteine
  • alpha lipoic acid
  • aviptadil
  • bevacizumab
  • bismuth
  • BLD-2660 (calpain inhibitor)
  • calcium channel blocker
  • camostat mesilate
  • continuous positive airway pressure (CPAP)
  • cytokine adsorption
  • diammonium glycyrrhizinate
  • dipyridamol
  • DPP-4 inhibitor
  • enoxaparin
  • famotidine
  • kinin-kallikrein inhibitors
  • levamisole
  • metformin
  • natural killer (NK) cells
  • nicotin
  • nitric oxide (gas Inhalation or releasing solution)
  • ozonated autohemotherapy
  • pamrevlumab
  • povidone-iodine
  • proton pump inhibitors (PPI)
  • proxalutamide
  • PUL-042 inhalation solution
  • radiotherapy
  • selinexor
  • statins
  • stem cells
  • tradipitant
  • tranilast
  • zinc
  • zinc plus hydroxychloroquine
  • vaccines
  • Ad26.COV2.S A EFFACER
  • BBV152 (Bharat Biotech, India)
  • BCG vaccination
  • CureVac
  • DNA vaccine
  • bacTRL-Spike
  • Inactivated virus vaccine
  • Covaxin, Bharat Biotech, Indian Council of Medical Research
  • Sinopharm Beijing (BBIBP-CorV)
  • Sinopharm Wuhan
  • SinoVac Biotech
  • Non replicating viral vector
  • CanSino
  • ChAdOx1 nCoV-19 (AstraZeneca Oxford)
  • JNJ-78436735 AD26 (Jonson
  • Sputnik V (Gam-COVID-Vac)
  • protein subunit vaccine
  • Anhui Zhifei Longcom
  • NVX-CoV2373 (Novavax)
  • RNA vaccine
  • Moderna COVID-19 vaccine
  • tozinameran (Pfizer/BIONTECH)
  • Sanofi/GSK recombinant protein vaccine
  • SCB-2019
  • virus-like particles vaccine
  • Medicago
  • Zy-Cov-D (Zydus Cadila)
  • vs. potential COVID-19 treatments
  • vs. antiviral and associated therapy
  • vs. oseltamivir
  • vs. control
  • All
  • COVID-19
  • COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  • COVID 19 outpatients
  • COVID-19 prophylaxis
  • infections other than COVID-19
  • preventing respiratory virus transmission